430 related articles for article (PubMed ID: 23905405)
21. The attractiveness of opposites: agonists and antagonists.
O'Brien T
J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
[TBL] [Abstract][Full Text] [Related]
22. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
23. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
[TBL] [Abstract][Full Text] [Related]
24. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.
Kurz A; Sessler DI
Drugs; 2003; 63(7):649-71. PubMed ID: 12656645
[TBL] [Abstract][Full Text] [Related]
25. Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature.
Brenner DM; Stern E; Cash BD
Curr Gastroenterol Rep; 2017 Mar; 19(3):12. PubMed ID: 28337726
[TBL] [Abstract][Full Text] [Related]
26. Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Hermanns K; Junker U; Nolte T
Expert Opin Pharmacother; 2012 Feb; 13(3):299-311. PubMed ID: 22224497
[TBL] [Abstract][Full Text] [Related]
27. Hot Topics in Primary Care: Management of Opioid-induced Constipation.
Johnson DA; Argoff CE
J Fam Pract; 2015 Dec; 64(12 Suppl):S4-9. PubMed ID: 26845012
[TBL] [Abstract][Full Text] [Related]
28. Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.
Clemens KE; Mikus G
Expert Opin Pharmacother; 2010 Feb; 11(2):297-310. PubMed ID: 20030568
[TBL] [Abstract][Full Text] [Related]
29. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
[TBL] [Abstract][Full Text] [Related]
30. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D
Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 23389876
[TBL] [Abstract][Full Text] [Related]
31. Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation.
Mueller-Lissner S
Adv Ther; 2010 Sep; 27(9):581-90. PubMed ID: 20714946
[TBL] [Abstract][Full Text] [Related]
32. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D
Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 22356224
[TBL] [Abstract][Full Text] [Related]
33. Management of opioid-induced bowel dysfunction in cancer patients.
Tamayo AC; Diaz-Zuluaga PA
Support Care Cancer; 2004 Sep; 12(9):613-8. PubMed ID: 15221581
[TBL] [Abstract][Full Text] [Related]
34. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
[TBL] [Abstract][Full Text] [Related]
35. Management of opioid-induced constipation for people in palliative care.
Prichard D; Bharucha A
Int J Palliat Nurs; 2015 Jun; 21(6):272, 274-80. PubMed ID: 26126675
[TBL] [Abstract][Full Text] [Related]
36. Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey.
Emmanuel A; Johnson M; McSkimming P; Dickerson S
Pain Med; 2017 Oct; 18(10):1932-1940. PubMed ID: 28339544
[TBL] [Abstract][Full Text] [Related]
37. Naloxegol for managing opioid-induced constipation.
Shelton KN; Clements JN
JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of peripheral opioid receptors.
Rachinger-Adam B; Conzen P; Azad SC
Curr Opin Anaesthesiol; 2011 Aug; 24(4):408-13. PubMed ID: 21659869
[TBL] [Abstract][Full Text] [Related]
39. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
Viscusi ER
Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777
[TBL] [Abstract][Full Text] [Related]
40. Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of Medicare beneficiaries.
Max EK; Hernandez JJ; Sturpe DA; Zuckerman IH
Am J Geriatr Pharmacother; 2007 Jun; 5(2):129-36. PubMed ID: 17719515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
